News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Asgard Therapeutics lead product AT-108 directly reprograms tumor cells within the TME
Photo from Asgard Therapeutics/X
Sep 10, 2024, 06:46

Asgard Therapeutics lead product AT-108 directly reprograms tumor cells within the TME

Asgard Therapeutics posted on X:

“Asgard Therapeutics’s new paper in Science showing how our lead product AT-108 directly reprograms tumor cells within the TME to become functional antigen-presenting dendritic cells, triggering strong anti-tumour responses.

More.”

Source: Asgard Therapeutics/X

 

Asgard Therapeutics AT-108 cancer Cristiana Pires OncoDaily Oncology
Special Coverage
Voices
Aug 15, 2025, 21:03
Drew Moghanaki: Cautionary Lessons from Dr. Mammarappallil on Percutaneous MWA for Lung Tumors
Voices
Aug 15, 2025, 21:01
Oliver Bogler: The NIH Review Process Doesn’t Have to Be a Mystery - Learn How to Navigate Study Section
Voices
Aug 15, 2025, 20:42
Heloisa Soares: Huntsman Cancer Institute Theranostics Program is Expanding
Insight
Aug 15, 2025, 20:14
Guilherme Harada: Honored to Have Contributed to This Study
Insight
Aug 15, 2025, 19:54
Rahul Banerjee: Faster, More Accurate Detection of Multiple Myeloma Progression
Voices
Aug 15, 2025, 19:27
Michael Chuong: Exciting Developments in RT for Pancreatic Cancer
Voices
Aug 15, 2025, 16:15
Theodoros Teknos: Case Comprehensive Cancer Center Awarded $25.5M NCI Cancer Center Support Grant
Science
Aug 15, 2025, 16:10
Saheli Sadanand: Excited to Share a New Cancer Vaccine Study in Nature Medicine
Voices
Aug 15, 2025, 16:00
Amy C Moore Highlights Persistent Challenges in Lung Cancer Survival and Research
Voices
Aug 15, 2025, 15:57
David Heredia Highlighted New Research on Membrane Targets in RET+ NSCLC
Voices
Aug 15, 2025, 15:57
Stephen Liu: Proud to Co-chair The 2026 Texas Lung Cancer Conference with Dr. Tina Cascone
Voices
Aug 15, 2025, 15:57
Minhua Chu: KRAS G12D Inhibitor GFH375 Delivers Strong Responses in NSCLC